The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: An Egyptian study

International Journal of Rehabilitation Research

Volumn 27, Issue 4, 2004, Pages 275-281

  El Etribi, M A ^a,c   Salem, M E ^a   El Shakankiry, H M ^b   El Kahky, A M ^b   El Mahboub, S M ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Botulinum toxin type A; Cerebral palsy; Children; Spasticity

Indexed keywords

CARRIER MOBILITY; NEUROLOGY; NEUROMUSCULAR REHABILITATION; PHYSICAL THERAPY; STATISTICAL METHODS;

CEREBRAL PALSY (CP); MYOSTATIC CONTRATURES; SPASTICITY;

TOXIC MATERIALS;

BOTULINUM TOXIN A; NEUROMUSCULAR BLOCKING AGENT;

ANKLE; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTRACTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EGYPT; GAIT; HUMAN; HYPERREFLEXIA; INJECTION; JOINT MOBILITY; MOBILIZATION; MOTONEURON; MUSCLE DENERVATION; MUSCLE TONE; NERVE CONDUCTION; NEUROMUSCULAR DISEASE; PASSIVE MOVEMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF CARE; SPASTICITY; TREATMENT OUTCOME;

ANKLE JOINT; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; EGYPT; FEMALE; GAIT; HUMANS; MALE; NEUROMUSCULAR AGENTS; PSYCHOMETRICS; RANGE OF MOTION, ARTICULAR;

EID: 11144221173     PISSN: 03425282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004356-200412000-00004     Document Type: Article

References (27)

1. Calderon GR, Calderon SRF, Rincon RM (1994). Botulinum toxin A in management of cerebral palsy. Pediatric Neurology 10:284-288.
2. Chutorian A, Root L (1994). Management of spasticity in children with botulinum A toxin. International Pediatrics 9:35-43.
3. Chutorian A, Root L, and the Botox Study Group (1995). A multicentre, randomized, double-blind placebo-controlled trial of botulinum toxin type A in the treatment of lower limb spasticity in pediatric cerebral palsy. Movement Disorders 10:364 (Abstract).
4. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor RC, Graham WK (1998). Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. Journal of Pediatric Orthopedics 18:304-311.
5. Cosgrove AP, Corry IS, Graham HK (1994). Botulinum toxin in the management of the lower limb in cerebral palsy. Developmental Medical Child Neurology 36:386-396.
6. Cosgrove AP, Graham HK (1992). Botulinum toxin-A in the management of spasticity with cerebral palsy. British Journal of Surgery 74B: 135-136.
7. De Luca PA (1996). The musculoskeletal management of children with cerebral palsy. Pediatric Clinics of North America 43:1135-1150.
8. Doll EA (1935). Vineland Social Maturity Scale: manual of directions (rev. ed.). 1st edition. Circle Pines, MN: American Guidance Service.
9. Anastasi A (1990). Tests for Special Populations. 6th edn. New York: Publishing Company; pp. 271-309.
10. Dukjin IM (1997). New approaches to managing spasticity in children with cerebral palsy. Western Journal of Medicine 166:271.
11. Hallett M (1995). Is dystonia a sensory disorder? Annals of Neurology 38: 139-140.
12. ICD-10 (1983). The ICD-10 classification of Mental and Behavioural Disorders, Diagnostic Criteria for Research. Geneva: World Health Organization.
13. Koman JA, Mooney JF, Mulvaney T, Roberts S, Smith BP (1993a). Further evaluation of botulinum A toxin (BOTOX) in the management of cerebral palsy. Developmental Medical Child Neurology 1:29.
14. Koman JA, Mooney JF III, Smith BP, Goodman A, Mulvaney T (1993b). Management of cerebral palsy with botulinum-A toxin: preliminary investigation. Journal of Pediatric Orthopedics 13:489-495.
15. Koman JA, Mooney JF III, Smith BP (1994a). Botulinum toxin: potential role in the management of cerebral palsy during childhood. In: Jankovic J, Hallett M (editors): Therapy with botulinum toxin. New York: Marcel Dekker; pp. 511-522.
16. Koman JA, Mooney JF III, Smith BP, Goodman A, Mulvane T (1994b). Management of spasticity in cerebral palsy with botulinum-A toxin: preliminary randomized double-blind trial. Journal of Pediatric Orthopedics 14: 299-303.
17. Koman LA, Mooney JF III, Smith BP, Walker F, Leon JM and the Botox Study Group (2000). Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. Journal of Pediatric Orthopedics 20:108-115.
18. Malika LK (1998). Stanford-Binet intelligence test (arabic translation). Faculty of Arts, Psychology Department: Ain Shams University.
19. Maragret J, Barry MS (1996). Physical therapy intervention for patients with movement disorders due to cerebral palsy. Journal of Child Neurology 11:51-58.
20. Rattey TE, Leahy L, Hyndman J, Brown DCS, Gross M (1993). Recurrence after Achilles tendon lengthening in cerebral palsy. Journal of Pediatric Ortnopedics 13:1407.
21. Reimers J (1993). Functional changes in the antagonists after lengthening of the agonists in cerebral palsy. Clinical Orthopedics 253:30-37.
22. Russman BS, Tilton A, Gormley ME (1997). Cerebral palsy: a rational approach to a treatment protocol and the role of botulinum toxin in treatment. Muscle Nerve 20(suppl. 6):5181-5193.
23. Suputtitada A (2000). Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report. American Journal of Physical and Medical Rehabilitation 79:320-326.
24. Swaiman KF (1999). Cerebral palsy. In: Swaiman KF, Ashwal S (editors): Pediatric neurology: principle and practice. 3rd edn. Mosby, pp. 312-324.
25. Sweif M, Mahmoud A, Magdi W (1980). Vineland Social Maturity Scale (arabic translation). Faculty of Arts, Psychology Department: Cairo University.
26. Terman LM (1916). The measurements of intelligence. Boston: Houghton, Mifflin.
27. Anastasi A (1990). Tests for special populations. In: Anastasi A (editor): Psychological Testing. 6th edn. New York: Macmillan Publishing Company; pp. 10-12.